-
Rotigotine and Bladder Function in Parkinsonian Rats
2026-09-08
This study shows that rotigotine produces route- and dose-dependent changes in bladder function in a 6-hydroxydopamine rat model of Parkinson’s disease. Its key contribution is the comparison of intravenous and subcutaneous delivery, revealing that subcutaneous treatment lengthened the intercontraction interval whereas intravenous treatment shortened it and reduced voiding pressure.
-
Hoechst 33258 for pH-Disruption Assays
2026-09-08
Learn how Hoechst 33258 can provide a DNA-centered readout for tumor-cell assays that perturb intracellular and extracellular pH. This guide connects minor-groove fluorescence, live-cell imaging, flow cytometry, and orthogonal lactate measurements without confusing nuclear staining with direct pH measurement.
-
Cholesterol in Translational mRNA–LNP Design
2026-09-07
Cholesterol is more than a membrane component: it is a controllable variable in lipid nanoparticle development. This thought-leadership article connects cholesterol biology with the reported intravesical p21 mRNA–LNP strategy for bladder cancer, while separating published evidence from practical formulation recommendations.
-
Putting Mammalian Embryos into Dormancy via mTOR
2026-09-07
This Nature Protocols study translates embryonic diapause into a controllable in vitro system by using pharmacological mTOR inhibition to induce a reversible, diapause-like state in mouse blastocysts, human blastoids, and pluripotent stem cells. The protocol provides a scalable framework for studying dormancy, developmental competence, and mTOR-dependent regulation without relying on invasive surgery.
-
Dual-Action Inhibition of p38α Dephosphorylation
2026-09-05
The reference preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can also expose the activation-loop phosphothreonine to the WIP1 phosphatase. This conformational mechanism offers a route to kinase inhibition that combines catalytic blockade with accelerated dephosphorylation, although its current evidence is primarily biochemical and structural.
-
DHCR7 Inhibition: From Sterols to Antiviral Design
2026-09-04
AY 9944 dihydrochloride provides a controllable chemical route to DHCR7 inhibition, 7-dehydrocholesterol accumulation, and cholesterol-dependent phenotyping. Paired with new dhcr7 knockout evidence in grass carp, it offers translational researchers a disciplined framework for connecting sterol metabolism, membrane organization, and antiviral immune biology without overstating what has been directly validated.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-04
Yin et al. identify a brain-to-spinal opioid pathway linking lateral parabrachial MOR neurons, hypothalamic dynorphin neurons, and spinal KOR-positive GABAergic neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance. The findings separate central control of mechanical pain from better-established thermal mechanisms and suggest that circuit-specific interventions may restore morphine responsiveness in mice.
-
SD 169 (indole-5-carboxamide) Assay Guide
2026-09-03
This scenario-based guide explains how SD 169 (indole-5-carboxamide), SKU C5850, can support controlled p38α/β pathway experiments in viability, apoptosis, type 1 diabetes, and axonal regeneration research. It connects formulation data with practical controls for interpretation, solvent handling, storage, and vendor selection.
-
BKT140: A CXCR4 Antagonist for Cancer Research
2026-09-03
Explore how BKT140 (BL-8040) converts CXCR4 biology into actionable oncology and stem-cell assays. This guide emphasizes assay selection, mechanistic interpretation, formulation, and translational decision-making beyond conventional theranostic reviews.
-
Stattic: STAT3 Inhibition Workflow for HNSCC
2026-09-02
Stattic enables mechanism-focused interrogation of STAT3 dimerization, nuclear translocation, survival signaling, and treatment response in cancer models. This guide translates its reported HNSCC activity into practical dose-response, pathway-validation, apoptosis, radiosensitization, and lymphatic endothelial workflows while emphasizing controls and troubleshooting.
-
Degarelix acetate: Practical GnRH Assay Workflows
2026-09-02
Build reproducible GnRH receptor, pituitary hormone, and prostate cancer research assays with concentration and handling strategies tailored to Degarelix acetate. A reference-backed isotope-labeling workflow also shows how to separate pharmacology experiments from LC–MS exposure analysis.
-
TH287 MTH1 Inhibitor for CRPC Radiosensitization
2026-09-01
TH287 converts oxidized nucleotide stress into a controllable vulnerability, helping researchers examine cancer cell selective cytotoxicity and radiation response. A CRPC study highlights treatment sequence as a major experimental variable, with the strongest combination effect when irradiation followed TH287 exposure by 12 hours.
-
Protease Inhibitor Cocktail for MS Workflows
2026-09-01
Protect extracted proteins with a broad-spectrum, AEBSF-free formulation designed for proteomics and biochemical workflows. This guide shows how to use the 50X DMSO stock, preserve cleavage-sensitive biology, and troubleshoot extraction, DMSO, metalloprotease, and mass spectrometry issues.
-
Olive Biophenols and Aβ42 Pathology in AD Models
2026-08-31
Omar and colleagues examined whether olive biophenols could inhibit Aβ42 aggregation under peptide-only, copper-associated, and L-DOPA-associated conditions, then tested an oleuropein-containing olive leaf extract in an APPswe/PS1dE9 mouse model. The study connects direct anti-amyloid activity with reduced SH-SY5Y toxicity and lower cortical and hippocampal plaque deposition, while also identifying bioavailability and blood–brain barrier penetration as unresolved translational questions.
-
Cardiogreen for Vascular Imaging and PDT
2026-08-31
Cardiogreen combines vascular-space fluorescence with a practical near-infrared light-activation workflow for diagnostics, cell assays, and exploratory tumor studies. This guide connects cardiac, hepatic, ophthalmic, and photodynamic applications with the calreticulin-centered immunology reported in oral squamous cell carcinoma research.